Could an antibiotic ingredient help smokers quit?
NCT ID NCT03713424
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether clavulanic acid, a drug used to boost antibiotics, can help people smoke less. Thirty adult smokers will take either the drug or a placebo for several weeks. Researchers will measure smoking levels and use brain scans to see if the drug changes how the brain responds to smoking-related images.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- clavulanic acid
- What this could lead to
- If it works, this could point toward a new medication to help people quit smoking by reducing cravings.
- What could go wrong
- This is a small, early-phase trial with only 30 participants. The drug may not reduce smoking more than placebo, and side effects are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOBACCO USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Missouri - Columbia
RECRUITINGColumbia, Missouri, 65211, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Personalized nicotine patch dosing may boost quit rates
- A stronger nicotine patch might break the dual Smoking-Vaping habit
- Could a child's doctor visit spark a parent's quit-smoking journey?
- Quit smoking from your couch: teleconsultation put to the test
- Can a smartphone app help smokers quit for good?
- Financial incentives and counseling aim to help homeless veterans quit smoking